EMS-CHEMIE HOLDING AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 854.8 USD | +3.23% |
|
+3.23% | +9.60% |
| Jul. 15 | Global markets live: Airbus, Burberry, AT&T, Boeing, Vinfast... |  |
| Jul. 12 | European shares hit over 1-month high on earnings, Fed rate-cut hopes | RE |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 35.68 and 31.8 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Specialty Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +9.60% | 18.91B | - | ||
| +23.61% | 70.02B | A- | ||
| -4.09% | 47.08B | A- | ||
| +22.30% | 44.25B | B+ | ||
| +35.36% | 29.07B | A- | ||
| +12.96% | 17.15B | B+ | ||
| -5.06% | 16.11B | B+ | ||
| -28.83% | 14.28B | A- | ||
| -29.23% | 12.17B | A- | ||
| +28.91% | 11.8B | A- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- EMSN Stock
- EMSHF Stock
- Ratings EMS-CHEMIE HOLDING AG
